AKI in hospitalized patients with COVID-19: a single-center experience.
Gaetano Alfano(University of Modena and Reggio Emilia), Giovanni Guaraldi(University of Modena and Reggio Emilia), Giulia Ligabue(University of Modena and Reggio Emilia), Francesco Fontana(Ospedale di Monfalcone), Riccardo Magistroni(University of Modena and Reggio Emilia), Erica Franceschini(University of Modena and Reggio Emilia), Francesco Giaroni(University of Modena and Reggio Emilia), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Giacomo Mori(University of Modena and Reggio Emilia), Margherita Digaetano(University of Modena and Reggio Emilia), Cristina Mussini(University of Modena and Reggio Emilia), Giacomo Cuomo(University of Modena and Reggio Emilia), Gianni Cappelli(FIND), Silvia Giovanella(University of Modena and Reggio Emilia), Niccolò Morisi(Azienda Ospedaliero-Universitaria di Modena), Andrea Bedini(Azienda Ospedaliero-Universitaria di Modena), Jovana Milić(University of Modena and Reggio Emilia)
PubMed
October 26, 2021
Cited by 2
Related Papers
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404